|
FEM1B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.8561818748708E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.43449737935953E-11 |
| Normal-vs-Stage2 |
2.42539999995017E-06 |
| Normal-vs-Stage3 |
3.99289490360388E-11 |
| Normal-vs-Stage4 |
3.60610430405472E-11 |
| Stage1-vs-Stage2 |
9.861000E-01 |
| Stage1-vs-Stage3 |
1.938160E-01 |
| Stage1-vs-Stage4 |
2.418300E-02 |
| Stage2-vs-Stage3 |
3.990800E-01 |
| Stage2-vs-Stage4 |
1.423200E-01 |
| Stage3-vs-Stage4 |
3.619000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.85673740008497E-13 |
| Normal-vs-AfricanAmerican |
7.217000E-04 |
| Normal-vs-Asian |
3.09419999622307E-08 |
| Caucasian-vs-AfricanAmerican |
3.608200E-01 |
| Caucasian-vs-Asian |
9.193600E-01 |
| AfricanAmerican-vs-Asian |
3.589800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.03816955032698E-12 |
| Normal-vs-Female |
1.49730228216072E-11 |
| Male-vs-Female |
2.152800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.28550014656082E-10 |
| Normal-vs-Age(41-60Yrs) |
4.79249973039941E-12 |
| Normal-vs-Age(61-80Yrs) |
2.93070012702401E-10 |
| Normal-vs-Age(81-100Yrs) |
2.002100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.393800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.184600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.933600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.320000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.109200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.754200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.639900E-02 |
| Classical-VS-Follicular |
1.378470E-02 |
| Classical-VS-Other |
9.657700E-02 |
| Classical-VS-Normal |
5.21940046738223E-10 |
| Tall-VS-Follicular |
9.519600E-01 |
| Tall-VS-Other |
4.055800E-01 |
| Tall-VS-Normal |
1.92919999975061E-07 |
| Follicular-VS-Other |
4.076000E-01 |
| Follicular-VS-Normal |
5.59170487690608E-11 |
| Other-VS-Normal |
3.825300E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.63484806090264E-12 |
| Normal-vs-N1 |
5.54040036071513E-10 |
| N0-vs-N1 |
3.183400E-01 |
|
|
